Skip to main content
SpringerLink
Log in

Kidney Imaging

  • Chapter
  • First Online:
Interventional Urology

Abstract

Renal imaging plays a fundamental role in the diagnoses and evaluation of patients with renal pathology. In urology, renal imaging is most commonly used in the evaluation of hematuria, trauma, and abdominal pain and the workup of genitourinary malignancy. Renal imaging is also utilized as follow-up studies for nephrolithiasis and surveillance of malignancy. The different imaging modalities utilized in disease diagnosis, response criteria status, staging, recurrence, restaging, or functional status include computerized tomography (CT), magnetic resonance imaging (MRI), diagnostic ultrasound (US), bone scan, nuclear medicine, and plain film X-ray. Positron emission tomography (PET) scanning with labeled antibody for imaging of renal cell carcinoma (RCC) is not currently a standard or recommended diagnostic measure and is still under evaluation. Applying the proper radiologic study is pertinent in each clinical situation and maximizes diagnostic accuracy while limiting radiation. Due to their superior diagnostic accuracy, CT and MRI are both used for detection and characterization of neoplasms suspicious for RCC. Kidney imaging also has the ability to allow for a better surgical planning prior to either nephron-sparing surgery or radical nephrectomy for renal tumors. This chapter will focus on the different imaging modalities available to diagnose and differentiate renal pathology with an emphasis on emerging techniques and modalities for the diagnosis and characterization of RCC and the role imaging plays as a biomarker of RCC subtypes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Kaufman DP, Basit H, Knohl SJ. Physiology, Glomerular Filtration Rate. [Updated 2020 Jul 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK500032/

  2. Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr Radiol. 1993;23(6):478–80.

    CAS  PubMed  Google Scholar 

  3. Nguyen HT, Benson CB, Bromley B, Campbell JB, Chow J, Coleman B, et al. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J Pediatr Urol. 2014;10(6):982–98.

    PubMed  Google Scholar 

  4. Hansen KL, Nielsen MB, Ewertsen C. Ultrasonography of the kidney: a pictorial review. Diagnostics (Basel). 2015;6(1):2.

    Google Scholar 

  5. Kazmierski B, Deurdulian C, Tchelepi H, Grant EG. Applications of contrast-enhanced ultrasound in the kidney. Abdom Radiol (NY). 2018;43(4):880–98.

    Google Scholar 

  6. Ignee A, Straub B, Brix D, Schuessler G, Ott M, Dietrich CF. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc. 2010;46(4):275–90.

    PubMed  Google Scholar 

  7. Ignee A, Straub B, Schuessler G, Dietrich CF. Contrast enhanced ultrasound of renal masses. World J Radiol. 2010;2(1):15–31.

    PubMed  PubMed Central  Google Scholar 

  8. Mytsyk Y, Borys Y, Komnatska I, Dutka I, Shatynska-Mytsyk I. Value of the diffusion-weighted MRI in the differential diagnostics of malignant and benign kidney neoplasms – our clinical experience. Pol J Radiol. 2014;79:290–5.

    PubMed  PubMed Central  Google Scholar 

  9. Zeccolini G, Del Biondo D, Cicero C, Casarin A, Guarise A, Celia A. Comparison of contrast-enhanced ultrasound scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases. Urologia. 2014;81(Suppl 23):S1–8.

    PubMed  Google Scholar 

  10. Juri H, Tsuboyama T, Koyama M, Yamamoto K, Nakai G, Nakamoto A, et al. Assessment of the ability of CT urography with low-dose multi-phasic excretory phases for opacification of the urinary system. PLoS One. 2017;12(4):e0174800.

    PubMed  PubMed Central  Google Scholar 

  11. Ertekin E, Amasyali AS, Erol B, Acikgozoglu S, Kucukdurmaz F, Nayman A, et al. Role of contrast enhancement and corrected attenuation values of renal tumors in predicting renal cell carcinoma (RCC) subtypes: protocol for a triphasic multi-slice computed tomography (CT) procedure. Pol J Radiol. 2017;82:384–91.

    PubMed  PubMed Central  Google Scholar 

  12. Sheth S, Fishman EK. Multi-detector row CT of the kidneys and urinary tract: techniques and applications in the diagnosis of benign diseases. Radiographics. 2004;24(2):e20.

    PubMed  Google Scholar 

  13. Zhu YH, Wang X, Zhang J, Chen YH, Kong W, Huang YR. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma. AJR Am J Roentgenol. 2014;203(3):W295–300.

    PubMed  Google Scholar 

  14. Kang SK, Huang WC, Pandharipande PV, Chandarana H. Solid renal masses: what the numbers tell us. AJR Am J Roentgenol. 2014;202(6):1196–206.

    PubMed  PubMed Central  Google Scholar 

  15. Jinzaki M, Tanimoto A, Mukai M, Ikeda E, Kobayashi S, Yuasa Y, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr. 2000;24(6):835–42.

    CAS  PubMed  Google Scholar 

  16. Wang JH, Min PQ, Wang PJ, Cheng WX, Zhang XH, Wang Y, et al. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol. 2006;186(5):1423–30.

    PubMed  Google Scholar 

  17. Hiorns MP. Imaging of the urinary tract: the role of CT and MRI. Pediatr Nephrol. 2011;26(1):59–68.

    PubMed  Google Scholar 

  18. Cox EF, Buchanan CE, Bradley CR, Prestwich B, Mahmoud H, Taal M, et al. Multiparametric renal magnetic resonance imaging: validation, interventions, and alterations in chronic kidney disease. Front Physiol. 2017;8:696.

    PubMed  PubMed Central  Google Scholar 

  19. Yu X, Lin M, Ouyang H, Zhou C, Zhang H. Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0T diffusion-weighted MRI. Eur J Radiol. 2012;81(11):3061–6.

    PubMed  Google Scholar 

  20. Ozulker T, Ozulker F, Ozbek E, Ozpacaci T. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses. Nucl Med Commun. 2011;32(4):265–72.

    PubMed  Google Scholar 

  21. Nakhoda Z, Torigian DA, Saboury B, Hofheinz F, Alavi A. Assessment of the diagnostic performance of (18)F-FDG-PET/CT for detection and characterization of solid renal malignancies. Hell J Nucl Med. 2013;16(1):19–24.

    PubMed  Google Scholar 

  22. Takahashi M, Kume H, Koyama K, Nakagawa T, Fujimura T, Morikawa T, et al. Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT. Clin Nucl Med. 2015;40(12):936–40.

    PubMed  PubMed Central  Google Scholar 

  23. Qichang W, Lin B, Gege Z, Youjia Z, Qingjie M, Renjie W, Bin J. Diagnostic performance of 18F-FDG-PET/CT in DTC patients with thyroglobulin elevation and negative iodine scintigraphy: a meta-analysis. Eur J Endocrinol. 2019;181(2):93–102.

    PubMed  Google Scholar 

  24. Oosterwijk-Wakka JC, Boerman OC, Mulders PF, Oosterwijk E. Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma. Int J Mol Sci. 2013;14(6):11402–23.

    PubMed  PubMed Central  Google Scholar 

  25. Khandani AH, Rathmell WK, Wallen EM, Ivanovic M. PET/CT with (124)I-cG250: great potential and some open questions. AJR Am J Roentgenol. 2014;203(2):261–2.

    PubMed  Google Scholar 

  26. Macis G, Di Giovanni S, Di Franco D, Bonomo L. [Future perspectives for diagnostic imaging in urology: from anatomic and functional to molecular imaging]. Urologia. 2013;80(1):29–41. (Article in Italian).

    Google Scholar 

  27. Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gonen M, Ruan S, et al. Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol. 2007;8(4):304–10.

    CAS  PubMed  Google Scholar 

  28. Nelson SM, Oettel DJ, Lisanti CJ, Schwope RB, Timpone VM. Incidental renal lesions on lumbar spine MRI: who needs follow-up? AJR Am J Roentgenol. 2019;212(1):130–4.

    PubMed  Google Scholar 

  29. Bosniak MA. The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol. 1997;157(5):1852–3.

    CAS  PubMed  Google Scholar 

  30. Agochukwu N, Huber S, Spektor M, Goehler A, Israel GM. Differentiating renal neoplasms from simple cysts on contrast-enhanced ct on the basis of attenuation and homogeneity. AJR Am J Roentgenol. 2017;208(4):801–4.

    PubMed  Google Scholar 

  31. Ellimoottil C, Greco KA, Hart S, Patel T, Sheikh MM, Turk TM, et al. New modalities for evaluation and surveillance of complex renal cysts. J Urol. 2014;192(6):1604–11.

    PubMed  Google Scholar 

  32. Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, et al. Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. Radiology. 2019;292(2):475–88. https://doi.org/10.1148/radiol.2019182646.

    Article  PubMed  Google Scholar 

  33. Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844–53.

    PubMed  Google Scholar 

  34. Kolla SB, Spiess PE, Sexton WJ. Interobserver reliability of the RENAL nephrometry scoring system. Urology. 2011;78(3):592–4.

    PubMed  Google Scholar 

  35. Vilaseca RM, Westphalen AC, Reis HF, Zogbi OS, Silva GE, Dos Reis RB, et al. Reproducibility and interobserver agreement of the R.E.N.A.L. nephrometry score: focus on imaging features. Radiol Bras. 2017;50(1):7–12.

    PubMed  PubMed Central  Google Scholar 

  36. Okhunov Z, Rais-Bahrami S, George AK, Waingankar N, Duty B, Montag S, et al. The comparison of three renal tumor scoring systems: C-Index, P.A.D.U.A., and R.E.N.A.L. nephrometry scores. J Endourol. 2011;25(12):1921–4.

    PubMed  Google Scholar 

  37. Corradi RB, Vertosick EA, Nguyen DP, Vilaseca A, Sjoberg DD, Benfante N, et al. Nephrometry scores and perioperative outcomes following robotic partial nephrectomy. Int Braz J Urol. 2017;43(6):1075–83.

    PubMed  PubMed Central  Google Scholar 

  38. Bata P, Gyebnar J, Tarnoki DL, Tarnoki AD, Kekesi D, Szendroi A, et al. Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT. Diagn Interv Radiol. 2013;19(5):387–92.

    PubMed  Google Scholar 

  39. Lopes Vendrami C, Parada Villavicencio C, DeJulio TJ, Chatterjee A, Casalino DD, Horowitz JM, et al. Differentiation of solid renal tumors with multiparametric MR imaging. Radiographics. 2017;37(7):2026–42.

    PubMed  Google Scholar 

  40. Pierorazio PM, Hyams ES, Tsai S, Feng Z, Trock BJ, Mullins JK, et al. Multiphasic enhancement patterns of small renal masses (</=4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology. 2013;81(6):1265–71.

    PubMed  Google Scholar 

  41. Bird VG, Kanagarajah P, Morillo G, Caruso DJ, Ayyathurai R, Leveillee R, et al. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol. 2011;29(6):787–92.

    CAS  PubMed  Google Scholar 

  42. Kopp RP, Aganovic L, Palazzi KL, Cassidy FH, Sakamoto K, Derweesh IH. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula. Can J Urol. 2013;20(3):6790–7.

    PubMed  Google Scholar 

  43. Mittal MK, Sureka B. Solid renal masses in adults. Indian J Radiol Imaging. 2016;26(4):429–42.

    PubMed  PubMed Central  Google Scholar 

  44. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002;168(6):2395–400.

    PubMed  Google Scholar 

  45. Canvasser NE, Kay FU, Xi Y, Pinho DF, Costa D, de Leon AD, et al. Diagnostic accuracy of multiparametric magnetic resonance imaging to identify clear cell renal cell carcinoma in cT1a renal masses. J Urol. 2017;198(4):780–6.

    PubMed  PubMed Central  Google Scholar 

  46. Pedrosa I, Alsop DC, Rofsky NM. Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer. 2009;115(10 Suppl):2334–45.

    PubMed  Google Scholar 

  47. Chiarello MA, Mali RD, Kang SK. Diagnostic accuracy of MRI for detection of papillary renal cell carcinoma: a systematic review and meta-analysis. AJR Am J Roentgenol. 2018;211(4):812–21.

    PubMed  PubMed Central  Google Scholar 

  48. Mileto A, Marin D, Alfaro-Cordoba M, Ramirez-Giraldo JC, Eusemann CD, Scribano E, et al. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study. Radiology. 2014;273(3):813–20.

    PubMed  Google Scholar 

  49. Raman SP, Johnson PT, Allaf ME, Netto G, Fishman EK. Chromophobe renal cell carcinoma: multiphase MDCT enhancement patterns and morphologic features. AJR Am J Roentgenol. 2013;201(6):1268–76.

    PubMed  Google Scholar 

  50. Lin TF, Lin WR, Chen M, Dai SH, Sun FJ, Tsai WK, et al. Compare Fuhrman Nuclear and chromophobe tumor grade on chromophobe RCC. Open Med (Wars). 2019;14:336–42.

    Google Scholar 

  51. Jinzaki M, Silverman SG, Akita H, Mikami S, Oya M. Diagnosis of renal angiomyolipomas: classic, fat-poor, and epithelioid types. Semin Ultrasound CT MR. 2017;38(1):37–46.

    PubMed  Google Scholar 

  52. Flum AS, Hamoui N, Said MA, Yang XJ, Casalino DD, McGuire BB, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol. 2016;195(4 Pt 1):834–46.

    PubMed  Google Scholar 

  53. Israel GM, Bosniak MA. Renal imaging for diagnosis and staging of renal cell carcinoma. Urol Clin North Am. 2003;30(3):499–514.

    PubMed  Google Scholar 

  54. Wobker SE, Williamson SR. Modern pathologic diagnosis of renal oncocytoma. J Kidney Cancer VHL. 2017;4(4):1–12.

    PubMed  PubMed Central  Google Scholar 

  55. Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017;35(3):379–87.

    PubMed  Google Scholar 

  56. Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11(2):102–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Sasamori H, Saiki M, Suyama J, Ohgiya Y, Hirose M, Gokan T. Utility of apparent diffusion coefficients in the evaluation of solid renal tumors at 3T. Magn Reson Med Sci. 2014;13(2):89–95.

    PubMed  Google Scholar 

  58. Wang Y, Tanaka H, Ye Y, Ding X, Ward RD, Campbell RA, et al. The complete spectrum of infiltrative renal masses: clinical characteristics and prognostic implications. Urology. 2019;130:86–92.

    PubMed  Google Scholar 

  59. Ziemba JB, Matlaga BR. Epidemiology and economics of nephrolithiasis. Investig Clin Urol. 2017;58(5):299–306.

    PubMed  PubMed Central  Google Scholar 

  60. Brisbane W, Bailey MR, Sorensen MD. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016;13(11):654–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Semins MJ, Matlaga BR. Kidney stones during pregnancy. Nat Rev Urol. 2014;11(3):163–8.

    PubMed  Google Scholar 

  62. Dhar M, Denstedt JD. Imaging in diagnosis, treatment, and follow-up of stone patients. Adv Chronic Kidney Dis. 2009;16(1):39–47.

    PubMed  Google Scholar 

  63. Masselli G, Weston M, Spencer J. The role of imaging in the diagnosis and management of renal stone disease in pregnancy. Clin Radiol. 2015;70(12):1462–71.

    CAS  PubMed  Google Scholar 

  64. Kalb B, Sharma P, Salman K, Ogan K, Pattaras JG, Martin DR. Acute abdominal pain: is there a potential role for MRI in the setting of the emergency department in a patient with renal calculi? J Magn Reson Imaging. 2010;32(5):1012–23.

    PubMed  Google Scholar 

  65. Krepkin K, Won E, Ramaswamy K, Triolo M, Stiffelma M, Rusinek H, et al. Dynamic contrast-enhanced MR renography for renal function evaluation in ureteropelvic junction obstruction: feasibility study. AJR Am J Roentgenol. 2014;202(4):778–83.

    PubMed  Google Scholar 

  66. Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198(3):520–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA

    Michael Daneshvar & Gennady Bratslavsky

Authors
  1. Michael Daneshvar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gennady Bratslavsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gennady Bratslavsky .

Editor information

Editors and Affiliations

  1. Urology and Radiology, Lenox Hill Hospital, New York, NY, USA

    Ardeshir R. Rastinehad

  2. Vascular & Interventional Radiology, North Shore Long Island Jewish Health System, New Hyde Park, NY, USA

    David N. Siegel

  3. National Cancer Institute & Clinica, Bethesda, MD, USA

    Bradford J. Wood

  4. Lefrak Center for Robotic Surgery, Weill Cornell Medicine, New York, NY, USA

    Timothy McClure

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Daneshvar, M., Bratslavsky, G. (2021). Kidney Imaging. In: Rastinehad, A.R., Siegel, D.N., Wood, B.J., McClure, T. (eds) Interventional Urology . Springer, Cham. https://doi.org/10.1007/978-3-030-73565-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-73565-4_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-73564-7

  • Online ISBN: 978-3-030-73565-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation